Estrogen carcinogenesis in the hamster kidney: a hormone-driven multistep process

Area of Science:

• Endocrinology
• Neoplastic Transformation
• Renal Cell Biology

Background:

• Estrogens can induce kidney cytotoxicity and subsequent cell proliferation.
• Chronic hormone treatment is linked to renal tumorigenesis in hamsters.
• The specific mechanisms driving estrogen-induced renal tumors require elucidation.

Purpose of the Study:

• To investigate the sequence of events leading to estrogen-induced renal tumorigenesis in hamsters.
• To determine if the intrinsic estrogenic property drives kidney damage and cell proliferation.
• To identify molecular events in early-stage, hormonally driven kidney cancer.

Main Methods:

• Chronic estrogen administration to hamsters.
• Monitoring of kidney proximal tubule (PCT) cell alterations, including estrogen receptor (ER) and progesterone receptor (PR) expression.
• Assessment of PCT cytotoxicity, cell injury, and regenerative cell proliferation.
• Analysis of chromosomal instability and gene expression (protooncogenes, suppressor genes).

Main Results:

• Estrogen treatment led to increased ER and PR levels in PCT cells, indicating heightened responsiveness.
• Progressive PCT cytotoxicity and cell injury were observed, increasing with exposure duration.
• Regenerative cell proliferation occurred in mature proximal tubules and interstitial stem cells.
• Significant elevation in aneuploid cells and chromosomal aberrations (trisomies, tetrasomies, monosomies) was detected.
• Overexpression of protooncogenes and suppressor genes occurred by 4 months.

Conclusions:

• Estrogen-induced renal tumorigenesis in hamsters is driven by the intrinsic estrogenic property.
• The process involves a cascade of events: receptor upregulation, cytotoxicity, regenerative proliferation, and genetic instability.
• Neoplastic transformation is a hormonally dependent, nongenotoxic process occurring in discrete molecular steps.